SARS-CoV-2 Nucleoprotein, His-Tag (E. coli)
SARS-CoV-2 Nucleoprotein is a recombinant antigen manufactured in E. coli cells to high purity for use in vaccine research and immunoassay development. SARS-CoV-2, previously known as the 2019 Novel C...
The Native Antigen Company
Founded in 2010, The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Our portfolio of reagents continues to expand rapidly, and we are widely acknowledged to be a primary source of reagents and kits for studying emerging diseases.
SARS-CoV-2 Spike Glycoprotein (S2), His-Tag (Insect Cells)
SARS-CoV-2 Spike Glycoprotein (S2) is a recombinant antigen which contains the Spike protein amino acids 685-1211 of subunit 2. Spike S2 protein is manufactured to high yield and purity using the Nat...
SARS-CoV-2 Spike-E-M Mosaic Protein, His-Tag (E. coli)
SARS-CoV-2 Spike-E-M Mosaic protein is a recombinant antigen manufactured in E. coli with greater than 95% purity, and containing the Spike (S), Envelope (E) and Membrane (M) immunodominant regions. ...
Human Coronavirus 229E Nucleoprotein (E. coli)
Human Coronavirus 229E Nucleoprotein is a recombinant protein containing 359 amino acids derived from the nucleocapsid sequence, with a C-terminal 6xHis tag. It is manufactured in E. coli with greater...
Human Coronavirus NL63 Nucleoprotein (E. coli)
Human Coronavirus NL63 Nucleoprotein is a recombinant protein containing the nucleocapsid C-terminal region (130 amino acids), cloned and expressed in E. coli, and purified by affinity chromatography...
Browse Products by Field
Founded in 2010, The Native Antigen Company has rapidly become one of the world’s leading suppliers of infectious disease reagents. Our portfolio of reagents continues to expand rapidly, and we are widely acknowledged to be a primary source of reagents and kits for studying emerging diseases.
The Native Antigen Company are a leading supplier of native and recombinant viral and bacterial antigens, antibodies and immunoassays, alongside bespoke custom and contract services. Its infectious disease reagents are widely adopted by pharmaceutical, in vitro diagnostics and vaccine manufacturers, as well as leading academic groups in cutting-edge research, where correct folding and glycosylation of proteins is vital. We also offer our expertise on a contract basis to other sectors where highly purified proteins are required. It is an ethical and sustainable organisation and are proud of the long-term relationships with customers and partners.
Contact The Native Antigen Company
BUILDING B LANGFORD LOCKS KIDLINGTON, OXFORD OXFORDSHIRE OX5 1LH UNITED KINGDOM
Website link